Healthcare - Biotechnology - NASDAQ - US
$ 0.4612
-9.85 %
$ 18.5 M
Market Cap
-0.5
P/E
BALANCE SHEET
35.2 M
ASSETS
10.7 M
LIABILITIES
24.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cognition Therapeutics, Inc.
| Current Assets | 34.2 M |
| Cash & Short-Term Investments | 29.9 M |
| Receivables | 1.28 M |
| Other Current Assets | 3.02 M |
| Non-Current Assets | 941 K |
| Long-Term Investments | 0 |
| PP&E | 941 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 10.2 M |
| Accounts Payable | 3.7 M |
| Short-Term Debt | 348 K |
| Other Current Liabilities | 6.13 M |
| Non-Current Liabilities | 520 K |
| Long-Term Debt | 1.04 M |
| Other Non-Current Liabilities | -520 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 29.9 | 41.6 | 54.7 | 5.2 | 2.9 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.3 | 3.7 | 2.3 | 1.2 | 4.1 |
| Inventory | 0 | 0 | 2.0 | 0.5 | 0.1 |
| Other Current Assets | 3.0 | 2.4 | 2.0 | 0.6 | 0.1 |
| Total Current Assets | 34.2 | 47.6 | 59.0 | 6.9 | 7.2 |
| PP&E | 0.9 | 1.0 | 0.1 | 0.2 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 1.7 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 35.2 | 50.4 | 59.1 | 7.1 | 7.5 |
| LIABILITIES | |||||
| Accounts Payable | 3.7 | 3.2 | 4.2 | 2.0 | 2.4 |
| Short Term Debt | 0.3 | 0.3 | 0 | 0 | 4 K |
| Other Current Liabilities | 4.4 | 2.6 | 3.7 | 1.2 | 1.3 |
| Total Current Liabilities | 10.2 | 7.8 | 7.9 | 3.2 | 3.7 |
| Long Term Debt | 1.0 | 1.4 | 0 | 12.9 | 6.9 |
| Deferred Tax Income | 0 | (0.7) | 0 | 0 | 0 |
| Other Liabilities | (0.5) | (0.7) | 0 | 59.2 | 55.3 |
| Total Liabilities | 10.7 | 10.2 | 7.9 | 75.3 | 65.9 |
| EQUITY | |||||
| Common Stock | 32 K | 29 K | 22 K | 1 K | 1 K |
| Retained Earnings | (141.2) | (115.4) | (94.0) | (68.2) | (58.2) |
| Other Accumulative Comprehensive Income/Loss | (0.2) | (0.2) | (0.2) | (0.2) | (0.2) |
| Total Equity | 24.5 | 40.2 | 51.3 | (68.2) | (58.4) |
| Total Liabilities and Equity | 35.2 | 50.4 | 59.1 | 7.1 | 7.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 30.0 | 29.0 | 22.2 | 21.9 | 21.9 |